Key result
Innovation stewardship in cardiac surgery is required to harmonize the short- and long-term clinical benefits of new devices with their significant financial costs.
Highlights the need for innovation stewardship in cardiac surgery to balance the clinical benefits of new technologies with their financial costs.
Modern cardiac surgery has rapidly evolved to treat complex cardiovascular disease. This past year boasted noteworthy advances in xenotransplantation, prosthetic cardiac valves, and endovascular thoracic aortic repair. Newer devices often offer incremental design changes while demanding significant cost increases that leave surgeons to decide if the benefit to patients justifies the increased cost. As innovations are introduced, surgeons must continuously aim to harmonize short- and long-term benefits with financial costs). We must also ensure quality patient outcomes while embracing innovations that will advance equitable cardiovascular care.
No takes yet. Share an insight, caveat, or question.
Netsanet et al. (2023) conducted an editorial in complex cardiovascular disease. Innovation stewardship in cardiac surgery is required to harmonize the short- and long-term clinical benefits of new devices with their significant financial costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: